Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/3392
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau |
Autor: | Santa María, Ismael CSIC ORCID CVN; Hernández, Félix; Río, Joaquín del CSIC; Moreno Muñoz, Francisco José; Ávila, Jesús CSIC ORCID | Fecha de publicación: | 6-sep-2007 | Editor: | BioMed Central | Citación: | Molecular Neurodegeneration 2: 17 (2007) | Resumen: | Alzheimer's disease (AD) is characterized by the presence of two histopathological hallmarks; the senile plaques, or extracellular deposits mainly composed of amyloid-β peptide (Aβ), and the neurofibrillary tangles, or intraneuronal inclusions composed of hyperphosphorylated tau protein. Since Aβ aggregates are found in the pathological cases, several strategies are under way to develop drugs that interact with Aβ to reduce its assembly. One of them is 3-amino-1-propane sulfonic acid (Tramiprosate, 3-APS, Alzhemed™), that was developed as a sulfated glycosaminoglycan mimetic, that could interact with Aβ peptide, preventing its aggregation. However, little is known about the action of 3-APS on tau protein aggregation. In this work, we have tested the action of 3-APS on cell viability, microtubule network, actin organization and tau aggregation. Our results indicate that 3-APS favours tau aggregation, in tau transfected non-neuronal cells, and in neuronal cells. We also found that 3-APS does not affect the binding of tau to microtubules but may prevent the formation of tau-actin aggregates. We like to emphasize the importance of testing on both types of pathology (amyloid and tau) the potential drugs to be used for AD treatment. | Descripción: | This article is available from: http://www.molecularneurodegeneration.com/content/2/1/17 | URI: | http://hdl.handle.net/10261/3392 | DOI: | 10.1186/1750-1326-2-17 | ISSN: | 1750-1326 |
Aparece en las colecciones: | (CBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
picrender.pdf | Principal | 684,34 kB | Adobe PDF | Visualizar/Abrir |
1750-1326-2-17-S1.pdf | Archivo adicional 1 | 415,12 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
25
checked on 09-mar-2024
SCOPUSTM
Citations
76
checked on 23-abr-2024
WEB OF SCIENCETM
Citations
62
checked on 29-feb-2024
Page view(s)
358
checked on 23-abr-2024
Download(s)
270
checked on 23-abr-2024